Jim Cramer says news on tariffs, FANG stocks, positive research, and the corporate outlook are fueling a stock market surprise.
Jim Cramer says Wall Street isn't very worried about tariffs. He highlights the stocks with China exposure and looks at the potential impact.
Jim Cramer takes a closer look at PayPal, Senseonomics, Idexx Laboratories, Sonos, Denbury Resources, Apptio, Invitae, Wayfair, JD.com, and McDonald's.
From a Sample of Over 10,000 Adults, 62 Percent are Worried They may Develop Alzheimer's Disease and 91 Percent Believe the Solution to Tackling Diseases Lies in Medical Research(1)
Amgen's migraine prevention drug Aimovig is understood to be superior to Teva's Ajovy.
Jim discusses a number of stocks, including Amgen, PayPal and Salesforce.
Ajovy is the second anti-calcitonin gene-related peptide (CGRP) drug approved by the FDA to prevent migraines.
The Trump administration has invited Chinese officials to a new round of trade negotiations later this month.
The most recent short interest data has been released for the 08/31/2018 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the Nasdaq 100 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.
THOUSAND OAKS, Calif., Sept.
Investors wrapped up a volatile week on Wall Street.
THOUSAND OAKS, Calif., Sept.
Designation Supported by Phase 2b PATHWAY Data That Demonstrated Tezepelumab Significantly Reduced Asthma Exacerbations Compared to Placebo in Severe Asthma Patients
Jim Cramer, celebrating the opening of the NFL season, says this is just another day of total tech mayhem.
Jim Cramer takes a look at United Parcel Service, TJX Companies, Anheuser-Busch InBev, Fiat Chrysler, AbbVie, Nvidia, Excelixis, Bank of America, Endo Pharmaceutical and more.
We look at Amgen, Citigroup and WestRock.
An Opportunity for Start-Ups to be Awarded a Golden Ticket
Markets pressed higher this week as the U.S. and Mexico came to an agreement on trade.
Amgen calls just look too cheap to pass up here.
Approval Based on Data From the Phase 1/2 '205 Study
The time has come to right-size this large position and take some shares off the table.
Filing Based on Data From Phase 3 Head-to-Head A.R.R.O.W. Study
Immunotherapy may be the future of fighting cancer and companies are racing to capitalize on that. We spoke with the CEO of the Damon Runyon Cancer Research Foundation to find out why.
Markets pushed higher this week with the S&P 500 hitting a record high and showing resilience through several politically volatile events.
The combination of these two sales on strength will replenish our cash position and provide us with additional flexibility.
Jim Cramer weighs in on Dropbox, XPO Logistics, Ford Motor Co., Acadia Pharmaceuticals, Avalara, and more.
Jim Cramer says we have a $19 trillion economy, and two-thirds of it is based on consumer spending -- not manufacturing, or sales, or industry.
New Research Evaluates the Benefit of LDL-C Lowering With Repatha Across Gender and Age
